Study of Patient Eligibility for Participation in Surgery Clinical Trials - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Study of Patient Eligibility for Participation in Surgery Clinical Trials

This study is currently recruiting participants.

Study NCT00019799. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Study of Patient Eligibility for Participation in Surgery Clinical Trials

Official Title ^†

Evaluation for NCI Surgery Branch Clinical Research Protocols

Brief Summary

RATIONALE: Evaluating patients for eligibility in clinical trials may help doctors plan more effective surgical treatment for patients who have cancer.

PURPOSE: This clinical trial is studying patients to determine if they are eligible for surgery clinical trials.

Detailed Description

OBJECTIVES:

Evaluate patient eligibility for participation in NCI Surgery Branch protocols.
Permit standard therapy for patients ineligible for active Surgery Branch protocols who present novel or unique clinical training opportunity or conditions requiring immediate intervention in order to avoid compromising patient's health.

OUTLINE: Patients undergo various diagnostic procedures and clinical testing to determine protocol eligibility. The testing and procedures may include HLA blood typing, hepatitis screen, HIV serology, fine-needle aspiration, open incisional or excisional biopsies, leukapheresis, arteriogram, laparoscopy, various nuclear medicine and imaging scans with or without contrast dye, or pulmonary function tests.

PROJECTED ACCRUAL: A total of 5,000 patients will be accrued for this study within 5 years.

Study Phase

Study Type ^†

Interventional

Study Design ^†

Screening

Primary Outcome Measure ^†

Secondary Outcome Measure ^†

Condition ^†

Unspecified Adult Solid Tumor, Protocol Specific

Intervention ^†

Procedure: physiologic testing

MEDLINE PMIDs

Links

Clinical trial summary from the National Cancer Institute's PDQ® database This link exits the ClinicalTrials.gov site

Recruitment Information Fields

Recruitment Status ^†

Recruiting

Enrollment ^†

5000

Start Date ^†

August 1999

Completion Date

Eligibility Criteria ^†

DISEASE CHARACTERISTICS:

Biopsy proven or suspected malignant disease

PATIENT CHARACTERISTICS:

Age:

16 and over

Performance status:

Not specified

Life expectancy:

Not specified

Hematopoietic:

Not specified

Hepatic:

Not specified

Renal:

Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy

Not specified

Chemotherapy

Not specified

Endocrine therapy

Not specified

Radiotherapy

Not specified

Surgery

Not specified

Other

No concurrent therapy unless ineligible for Surgery Branch protocol and standard therapy deemed to be in best interest of patient and suitable for training needs of Surgery Branch staff

Gender

Both

Ages

16 Years and older

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

United States

Administrative Information Fields

NCT ID ^†

NCT00019799

Organization ID

CDR0000067224

Secondary IDs ^††

NCI-99-C-0128

Study Sponsor ^†

NCI - Center for Cancer Research-Medical Oncology

Collaborators ^††

National Cancer Institute (NCI)

Investigators ^†

Study Chair:

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Information Provided By

National Cancer Institute (NCI)

Verification Date

April 2008

First Received Date ^†

July 11, 2001

Last Updated Date

October 18, 2008

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.